Merck started its Acceleron pursuit at $160 per share, but CEO Davis balked at paying more than $180

Merck started its Acceleron pursuit at $160 per share, but CEO Davis balked at paying more than $180
esagonowsky
Tue, 10/12/2021 – 11:23